GBIO Financial Analysis
GBIO Key Indicators
GBIO Income Statement
GBIO Balance Sheet
GBIO Cash Flow
Quarterly
| FY2024Q4 | FY2024Q3 | FY2024Q2 | FY2024Q1 | FY2023Q4 | FY2023Q3 | FY2023Q2 | FY2023Q1 | FY2022Q4 | FY2022Q3 | FY2022Q2 | FY2022Q1 | FY2021Q4 | FY2021Q3 | FY2021Q2 | FY2021Q1 | FY2020Q4 | FY2020Q3 | FY2020Q2 | FY2020Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 4.19M 45.52% | 7.55M 252.00% | 4.09M 364.89% | 4.06M | 2.88M | 2.15M | 880.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue from Goods & Services | 4.19M 45.52% | 7.55M 252.00% | 4.09M 364.89% | 4.06M | 2.88M | 2.15M | 880.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 4.19M 45.52% | 7.55M 252.00% | 4.09M 364.89% | 4.06M | 2.88M | 2.15M | 880.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General & Administrative Expenses | 24.15M -41.52% | 24.27M -27.56% | 25.90M -25.56% | 24.76M -28.98% | 41.30M 21.87% | 33.50M 2.55% | 34.80M 3.94% | 34.87M -1.35% | 33.89M 9.51% | 32.67M 3.19% | 33.48M 8.56% | 35.34M 37.77% | 30.95M 27.11% | 31.66M 50.98% | 30.84M 73.62% | 25.66M 42.24% | 24.35M | 20.97M | 17.76M 15.84% | 18.04M |
Research & Development Expense | 15.49M -44.51% | 15.09M -30.99% | 16.39M -24.94% | 14.34M -34.84% | 27.92M 34.20% | 21.86M 3.16% | 21.83M -6.56% | 22.00M -13.91% | 20.81M -4.76% | 21.19M -3.63% | 23.37M 3.13% | 25.55M 36.27% | 21.85M 33.42% | 21.99M 43.66% | 22.66M 68.37% | 18.75M 40.01% | 16.37M | 15.31M | 13.46M 9.96% | 13.39M |
Operating Profit | -19.96M -48.04% | -16.72M -46.69% | -21.81M -35.69% | -20.70M -40.62% | -38.42M 13.38% | -31.36M -4.02% | -33.92M 1.31% | -34.87M -1.35% | -33.89M 9.51% | -32.67M 3.19% | -33.48M 8.56% | -35.34M 37.77% | -30.95M 27.11% | -31.66M 50.98% | -30.84M 73.62% | -25.66M 42.24% | -24.35M | -20.97M | -17.76M 15.84% | -18.04M |
Financing Income- Net | 2.18M -32.58% | 2.57M -16.82% | 2.88M 0.84% | 3.09M 11.58% | 3.24M 41.70% | 3.09M 126.78% | 2.85M 416.85% | 2.77M 703.48% | 2.28M 76000.00% | 1.36M -791.88% | 552.00K 982.35% | 345.00K 270.97% | 3.00K -97.48% | -197.00K -264.17% | 51.00K 54.55% | 93.00K -70.85% | 119.00K | 120.00K | 33.00K -89.11% | 319.00K |
Interest Expense | -2.18M -32.58% | -2.57M -16.82% | -2.88M 0.84% | -3.09M 11.58% | -3.24M 41.70% | -3.09M 126.78% | -2.85M 416.85% | -2.77M 703.48% | -2.28M 76000.00% | -1.36M -791.88% | -552.00K 982.35% | -345.00K 270.97% | -3.00K -97.48% | 197.00K -264.17% | -51.00K 54.55% | -93.00K -70.85% | -119.00K | -120.00K | -33.00K -89.11% | -319.00K |
Other Non-Operating Income | 259.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income before Taxes | -21.38M -39.23% | -15.31M -45.83% | -20.43M -34.23% | -74.54M 132.26% | -35.19M 8.58% | -28.27M -9.71% | -31.07M -18.09% | -32.09M -8.30% | -32.41M 4.72% | -31.31M -1.72% | -37.93M 23.18% | -35.00M 36.92% | -30.94M 27.73% | -31.86M 52.79% | -30.79M 73.66% | -25.56M 44.28% | -24.23M | -20.85M | -17.73M 17.96% | -17.72M |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income after Tax | -21.38M -39.23% | -15.31M -45.83% | -20.43M -34.23% | -74.54M 132.26% | -35.19M 8.58% | -28.27M -9.71% | -31.07M -18.09% | -32.09M -8.30% | -32.41M 4.72% | -31.31M -1.72% | -37.93M 23.18% | -35.00M 36.92% | -30.94M 27.73% | -31.86M 52.79% | -30.79M 73.66% | -25.56M 44.28% | -24.23M | -20.85M | -17.73M 17.96% | -17.72M |
Income Available to Common Shares | -21.38M -39.23% | -15.31M -45.83% | -20.43M -34.23% | -74.54M 132.26% | -35.19M 8.58% | -28.27M -9.71% | -31.07M -18.09% | -32.09M -8.30% | -32.41M 4.72% | -31.31M -1.72% | -37.93M 23.18% | -35.00M 36.92% | -30.94M 27.73% | -31.86M 52.79% | -30.79M 73.66% | -25.56M 44.28% | -24.23M | -20.85M | -17.73M 17.96% | -17.72M |
EPS - Basic | -0.32 -39.62% | -0.23 -46.51% | -0.31 -34.04% | -1.12 111.32% | -0.53 -3.64% | -0.43 -18.87% | -0.47 -28.79% | -0.53 -13.11% | -0.55 -1.79% | -0.53 -5.36% | -0.66 20.00% | -0.61 32.61% | -0.56 12.00% | -0.56 21.74% | -0.55 41.03% | -0.46 48.39% | -0.50 | -0.46 | -0.39 50.00% | -0.31 |
EPS - Diluted | -0.32 -39.62% | -0.23 -46.51% | -0.31 -34.04% | -1.12 111.32% | -0.53 -3.64% | -0.43 -18.87% | -0.47 -28.79% | -0.53 -13.11% | -0.55 -1.79% | -0.53 -5.36% | -0.66 20.00% | -0.61 32.61% | -0.56 12.00% | -0.56 21.74% | -0.55 41.03% | -0.46 48.39% | -0.50 | -0.46 | -0.39 50.00% | -0.31 |
EBIT | -19.96M -48.04% | -16.72M -46.69% | -21.81M -35.69% | -20.70M -40.62% | -38.42M 13.38% | -31.36M -4.02% | -33.92M 1.31% | -34.87M -1.35% | -33.89M 9.51% | -32.67M 3.19% | -33.48M 8.56% | -35.34M 37.77% | -30.95M 27.11% | -31.66M 50.98% | -30.84M 73.62% | -25.66M 42.24% | -24.35M | -20.97M | -17.76M 15.84% | -18.04M |
EBITDA | -18.79M -49.36% | -15.54M -48.33% | -20.55M -36.97% | -19.39M -42.18% | -37.10M 13.99% | -30.06M -3.96% | -32.60M 1.07% | -33.54M -1.79% | -32.54M 9.27% | -31.31M 2.69% | -32.26M 8.57% | -34.15M 38.86% | -29.78M 27.52% | -30.49M 52.20% | -29.71M 75.41% | -24.59M 41.66% | -23.35M | -20.03M | -16.94M 13.08% | -17.36M |
Depreciation Depletion & Amortization | 1.18M -11.25% | 1.18M -8.74% | 1.26M -3.95% | 1.31M -1.35% | 1.33M -1.56% | 1.29M -5.21% | 1.32M 7.52% | 1.33M 11.11% | 1.35M 15.54% | 1.36M 16.28% | 1.22M 8.23% | 1.20M 12.50% | 1.17M 17.56% | 1.17M 24.92% | 1.13M 36.97% | 1.06M 57.16% | 991.00K | 939.00K | 825.00K 132.39% | 677.00K |
Free Financial AI Agent for Investment
Ask any investment related question and get answer instantly
Is GBIO earnings result positive or negative?How should I trade on GBIO earnings?GBIO FAQs
What is GBIO's PE Ratio in 2025/4/4?
GBIO's PE ratio in April 4, 2025 is -0.19. This indicates the price investors are willing to pay for $1 of earnings.
What is GBIO's PS Ratio in 2025/4/4?
GBIO's PS ratio in April 4, 2025 is 1.25. This indicates how much investors are willing to pay for each dollar of the company's sales.
What is GBIO's Dividend Yield in 2024/Q4?
GBIO's Dividend Yield in 2024/Q4 is 0.00%. This represents the return on investment from dividends relative to the stock price.
What is GBIO's Gross Margin in 2024/Q4?
GBIO's Gross Margin in 2024/Q4 is 100.00. Gross Margin is typically calculated as (Revenue - Cost of Goods Sold) / Revenue and is a key indicator of a company's financial health and efficiency in managing production costs.
Free Financial AI Agent for Investment
Ask any investment related question and get answer instantly
Is GBIO earnings result positive or negative?How should I trade on GBIO earnings?